Viatris Inc

Insider buys at Viatris spark optimism: Rogerio’s March purchases hint at future earnings upside and a potential turnaround for the pharma stock.

Viatris insider buying shows confidence amid volatility, backed by a solid generic pipeline, strong regulatory approvals, and potential earnings growth.

Viatris insider Maletta Matthew Joseph keeps 25 shares, hinting at long‑term confidence amid a 92% social‑media spike and neutral sentiment. Is the stock poised for a rebound?